Ideas to action: independent research for global prosperity
Malaria
More from the Series
WORKING PAPERS
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...
WORKING PAPERS
March 22, 2018
In this paper we combine fourteen years of high-resolution satellite data on forest loss with individual-level survey data on malaria in more than 60,000 rural children in 17 countries in Africa, and fever in more than 470,000 rural children in 41 countries in Latin America, Africa, and Asia. W...
Blog Post
September 15, 2017
Clear and rigorous evidence on the contributions of US global health programs is more important than ever, as the White House and lawmakers discuss and debate budgets and the future of US support to global health. Such information aids policymakers who must prioritize support to effective public hea...
Blog Post
December 15, 2015
This week, the Global Fund partnership will meet in Tokyo to plan for its fifth voluntary replenishment, covering the period 2017-2019. The stakes are high: in an austere budget climate, the Global Fund’s ability to raise the needed resources—and then to spend them effectively over the s...
Blog Post
November 25, 2015
The United Kingdom, in its new Aid Strategy out this week, and the Bill & Melinda Gates Foundation have jointly announced the creation of a £1 billion Ross Fund (named after a pioneering scientist) to fight malaria and neglected tropical diseases. But why not use the ex...